Global pharmacovigilance for Covid-19 vaccine
Linguamatics pioneers in global safety translation program for COVID-19 vaccine global safety monitoring
Linguamatics pioneers in global safety translation program for COVID-19 vaccine global safety monitoring
How Linguamatics helped establish a record-breaking safety program across 55 languages for COVID-19 vaccine
Our customer, a leading pharma company commercializing Covid19 vaccine, and its pharmacovigilance provider for safety monitoring were partnering with Linguamatics for the translation of adverse events.
As the pandemic hit record numbers on the global stage, the entire solution had to scale to absorb high volumes while delivering outstanding quality from all language sources, allowing safety protocols to be fully applied despite the crisis.
Our customer and its pharmacovigilance partner were faced with many challenges:
Linguamatics levered its integrated language solutions capabilities and layered them on top of the pharmacovigilance safety platform:
Thanks to its unique understanding of healthcare processes, Linguamatics can offer deep integration with any pharmacovigilance provider and fast track the scalability of capabilities across languages, while saving time and money in the process.
Linguamatics' partnership and integration into the pharmacovigilance platform allowed an end-to-end safety model which delivered the program successfully despite the extraordinary conditions: